Apidra (insulin glulisine) is the newest rapid-acting insulin
March 2006
Apidra (insulin glulisine) is the newest rapid-acting insulin.
It's a "me-too"...similar to Novolog and Humalog.
Patients will inject Apidra around meals...from 15 minutes before eating to 20 minutes after starting a meal.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote